In governing the Foundation, we are committed to the following principles:
- Have an external orientation to our decision-making; and
- Have logical connections between the use of our resources and the achievement of our objectives.
Responsible, larger risk-taking
We will focus on taking bigger risks to produce lasting results. This means that rather than making many small one-off grants, we will focus on larger multi-year grants with a greater potential for making a positive difference even if it involves a higher level of risk (risk means “either the failure to achieve the project’s objectives or non-performance”). For this approach to be successful, we will consider having a greater involvement in overseeing the management of the partnership, where deemed necessary.
Ethical and responsible behaviour
At all times, we will conduct every aspect of our activities in an ethical and responsible manner.
We will ensure that our values and those of our partners remain in alignment. We will not align exclusively to any political or religious movement group or organisation.
The Colonial Foundation is governed by a corporate trustee, Colonial Foundation Limited. The Directors of the Trustee are:
Alan Beanland - Chairman
Alan Beanland joined the Board in October 2010. He has extensive international experience across four continents in roles as a Director, Senior Executive, Consultant and Business Developer within the Information Technology and Finance sectors. He has also advised major Australian and Asian Groups on their international business expansion activities.
Mr Beanland is also Chairman of Orygen – The National Centre of Excellence In Youth Mental Health. He was previously Chairman of Credit Union Australia Limited (CUA) and a Non-Executive Director of CUA Heath Ltd, Credicorp Insurance Pty Ltd, Superpartners Pty Ltd, Spotless Group Limited, Dragon Mountain Gold Limited and Hancock Victorian Plantations Limited amongst other companies.
Geoffrey Donnan AO
Professor Geoffrey Donnan AO joined the Board in June2019. He is Professor of Neurology at The University of Melbourne and former Director of The Florey Institute of Neuroscience and Mental Health. He actively continues his research at the Royal Melbourne and Austin Hospitals where his major interests are in neuroimaging and clinical trials. He has made major contributions to the understanding of stroke including establishment of new risk factors, the duration and evolution of viable brain tissue after stroke, the ischaemic penumbra. More recently he has been co-chair of trials of thrombectomy in acute ischemic stroke with Professor Stephen Davis and the establishment of Australia’s first mobile stroke ambulance. Professor Donnan has previously served as a board member of the Stroke Foundation, Brain Foundation, Prince Henry’s Institute of Medical Research, The Florey Institute of Neuroscience and Mental Health, Australian Clinical Trials Alliance (ACTA), Melbourne Academic Centre for Health (MACH), World Stroke Organization and World Neurology Foundation.
Michael Fitzsimmons joined the Board in October 2020. He has had a successful career in institutional investing, with more than 30 years’ of experience managing equity portfolios for some of Australia’s largest investment institutions.
In 1998, Michael co-founded JCP Investment Partners (JCP), in a joint venture with Jardine Fleming Asset Management (and later JP Morgan AM). He was JCP’s Senior Portfolio Manager, Chief investment Officer, and Managing Director from 1999 until 2018. Before this, Michael was the Head of Australian Equities at ANZ Funds Management. He is a Senior fellow of the Financial Services Institute of Australasia (FINSIA).
Michael retired as an executive in 2018 and is currently studying for a Masters degree at Deakin University and managing his family farm and vineyard in Central Victoria.
Colin Galbraith AM
Colin Galbraith joined the Board in March 2013 and is a Special Advisor to Gresham Partners Limited. Mr Galbraith joined Gresham in 2006 after retiring from the partnership of the law firm Allens Arthur Robinson.
Mr Galbraith is the Chairman of CARE Australia and a Trustee of the Royal Melbourne Hospital Neuroscience Foundation. Formerly, he was a Director of Latam Autos Limited, the Commonwealth Bank of Australia and the Australian Institute of Company Directors.
Robert Garnsworthy joined the Board in February 2015. He worked for 17 years with Shell Australia holding executive positions in Shell’s Canadian and London offices. Mr Garnsworthy joined the Colonial Group of companies in 1994 and was Managing Director of Colonial’s United Kingdom’s office up to 1998, thereafter, Managing Director of Colonial International from 1998 through to 2000. Mr Garnsworthy was Chief Executive Officer of Norwich Union Australia from 2000 to 2003.
His previous Board roles include Colonial First State, Portfolio Partners and CGU Insurance.
Andrea Waters joined the Board in February 2018. She is a Fellow of Chartered Accountants Australia & New Zealand, a member and accredited facilitator of the Australian Institute of Company Directors and a former partner with KPMG (until 2012) specialising in Financial Services Audit. For the past eight years Ms Waters has been a professional Non-Executive Director and is currently a Director of MyState Limited (MYS), Genworth Mortgage Insurance Australia Limited (GMA), Grant Thornton Australia Limited, Bennelong Funds Management Group and Citywide Service Solutions Pty. Ltd. She was previously a Director of Cash Converters International Limited (CCV), Care Super, The Lord Mayors Charitable Foundation, Chartered Accountants Australia & New Zealand and Cancer Council Victoria.
André Carstens – Chief Executive Officer and Company Secretary
Michelle Donovan – Personal Assistant